Navigation Links
Smith & Nephew Advanced Wound Management Comments on Temporary Injunction in United Kingdom
Date:1/14/2009

e clinician can exercise her or his own best judgment when tailoring negative pressure wound therapy for each patient."

For more information regarding Smith & Nephew, please visit our Web site at www.smith-nephew.com

About Smith & Nephew

Smith & Nephew is a global medical technology business, specializing in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were nearly $3.4 billion.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Sm
'/>"/>

SOURCE Smith & Nephew's Advanced Wound Management
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
2. GlaxoSmithKline Responds to JAMA Articles
3. The Will and Jada Smith Family Foundation and Maybelline Join Forces With the Lupus Foundation of America for a Star-studded Gala to Raise Awareness for Lupus
4. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
5. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
6. TIGroup Names Dennis M. Smith as Chief Financial Officer
7. The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer
8. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
9. Smith & Nephew Endoscopys KINSA(R) RC Suture Anchor Designed for Secure Repair of Rotator Cuff Injuries
10. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
11. Smithfield(R) LEAN GENERATION(R) Announces DELI FOR THE CURE(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...es may reduce future disease burden, researchers s...-- Encouraging city dwellers to walk and bicycle i...ic health benefits than increased used of low-emis...he study compared the projected health effects in ... for London, England, and Delhi, India: business-...
(Date:11/27/2009)...e; announced today that Spectrum Health (Grand Rap...se orthopedic templating solution and its TraumaCa... (PRWEB) November 27, 2009 -- Voyant Health&tr...apids, Michigan) has licensed its TraumaCad Enterp...Cad Extend workflow solution, to allow its orthope...
(Date:11/27/2009)...ive anatomy education apps from Modality and Lippi...s learning opportunities for iPhone and iPod touch...ember 27, 2009 -- Modality, Inc. and Lippincott ...s Kluwer Health, today announced the availability ...re. Clemente’s Anatomy, Rohen’s Photog...
(Date:11/26/2009)...ans living with diabetes will nearly double, incre... 2034. Over the same period, spending on diabetes ...36 billion, even with no increase in the prevalenc...of Chicago report in the December issue of Diabet...vered by Medicare will rise from 8.2 million to 14...
(Date:11/26/2009)...l rollercoaster, study finds , , THURSDA...ctor meets the jubilant sports fan. , A new stu...o root for the winning team -- enjoy the greatest ... victory was in doubt, producing feelings of worry...ving weekend as you,re glued to the TV set, watchi...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
...al Corporation,(OTC Bulletin Board: CONX), a world...s, reported sales of $2,001,896 for the first fisc... $2,105,188 for the quarter,ended September 30, 20... The first quarter of fiscal 2009 produced an oper...
...orts and,Nutritional Supplements developer and man...TNI) announced today that the company,s primary op...ional, Inc. (INII) has signed a,five year exclusiv...urdur Arnason. The contract calls for minimum,purc...
...utical Company,(NYSE: KVa ; KVb) announced that i...Commission a Form 12b-25 notification that its Qua...eptember 30, 2008 will be delayed., About KV Phar...ires,technology-distinguished branded and generic/...
...e the majority of employers believe the best way t...overhaul, they are confident that the U.S. should ...ystem. , Brookfield, Wisc...hey are confident that the U.S. should not move aw...
...cent innovation in laser skin treatments combines ...ent Dual Mode RF System uses unipolar and bipolar ...n both shallow and deep tissue depths. The technol...WEB) November 13, 2008 -- A new skin rejuvenation...
...uest Biosciences, Inc. a,development stage pain ma...d and Drug Administration (FDA) has accepted its I...-1015, its abuse deterrent extended release,strong...cer of TheraQuest stated,"Sustained release opioid...
Other Medicine News:Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 3Health News:Natural Nutrition Canadian Subsidiary Signs $50.5 Million (CDN) Five Year European Distribution Contract 2Health News:KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q 2Health News:KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q 3Health News:KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q 4Health News:Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues. 2Health News:Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues. 3Health News:Accent Dual Mode Skin Tightening Laser is Latest Offering from Juva Skin Center 2Health News:TheraQuest's IND for Abuse Deterrent Strong Opioid (TQ-1015) Accepted by FDA 2
(Date:11/26/2009)..., , JOHANNESBURG, South Africa, Nov. 26 ...h Africa Company of the Year Award in the Generic ... South Africa Limited. ,, (Logo: http://www.ne... the Company of the Year Award, the following crit...ance against key competitors: growth strategy and ...
(Date:11/25/2009)..., , PRINCETON, N.J., Nov. 25 /PRNewswire-Fi...linical stage pharmaceutical company committed to ...drugs to treat viral infections, reported financia...2009. At September 30, 2009 Pharmasset held $58.4 ...nvestments. ,, Pipeline Update and 2009 Highl...
(Date:11/25/2009)..., , WEST PALM BEACH, Fla., Nov. 25 /PRNews...ring impaired Americans, especially the 27 million...s may not be all that happy, says audiologist Cind... HearUSA (Amex: EAR ), one of America,s largest h...dies have linked hearing loss to stress, frustrati...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Micromet Announces Pricing of Public Offering of Common Stock 13287 1Micromet Announces Pricing of Public Offering of Common Stock 13287 2Micromet Announces Pricing of Public Offering of Common Stock 13287 3Micromet Announces Pricing of Public Offering of Common Stock 13287 4Breakthrough Nursing Home Alternative Now Available to Cincinnati Elders and Their Families at Deupree Cottages 53216 1Breakthrough Nursing Home Alternative Now Available to Cincinnati Elders and Their Families at Deupree Cottages 53216 2Breakthrough Nursing Home Alternative Now Available to Cincinnati Elders and Their Families at Deupree Cottages 53216 3MedPro Scores 87 Percent Sales Revenue Increase in Second Quarter 53213 1MedPro Scores 87 Percent Sales Revenue Increase in Second Quarter 53213 2
...SA meetings this week, SAN DIEGO, Oct. 23 Mpex P...inical and preclinical results with MP-376, the,co...solution delivered by,an Investigational eFlow Neb...chronic obstructive pulmonary disease (COPD). Clin...s well tolerated at all dose levels tested,after 1...
...n Schultz will present a new initiative with St. T...e to support spinal cord injury research.,St. Thom...ett - a leader in,spinal cord injury research - an...yn M. Casale will provide details on STU current s...nancial aid opportunities for minority,students - ...
Other Medicine Technology:Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 2Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 3Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 4Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 5Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 6
...trade; RT cannulas are all able to be used with th...RT system. , ,The VERSAPORT™ RT cannulas ar...ms packaged for use with the RT system. The trocar...ade; Plus V2, SURGISPIKE™ (5mm only, no dila...
VERSAPORT™ Plus RT Single Use Obturators
SURGISPIKE™ Non-Shielded Single Use 5 mm Trocar
...e™ SPRING-GRIP™ single use nonconducti... 11 mm and 12 mm sizes for use with the SURGIPORT&... mm-11 mm, 5 mm-12 mm and 10 mm-15 mm sizes for us...EMIUM SURGIPORT™, SURGIPORT™ III and V...
Medicine Products: